These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6543600)

  • 1. Glial fibrillary acidic protein (GFAP) immunoreactivity in peripheral nerve sheath tumors.
    Memoli VA; Brown EF; Gould VE
    Ultrastruct Pathol; 1984; 7(4):269-75. PubMed ID: 6543600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors.
    Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
    Hum Pathol; 1989 Nov; 20(11):1089-96. PubMed ID: 2478442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.
    Kawahara E; Oda Y; Ooi A; Katsuda S; Nakanishi I; Umeda S
    Am J Surg Pathol; 1988 Feb; 12(2):115-20. PubMed ID: 3124642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
    Giangaspero F; Fratamico FC; Ceccarelli C; Brisigotti M
    Appl Pathol; 1989; 7(2):134-44. PubMed ID: 2471540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas.
    Johnson MD; Glick AD; Davis BW
    Arch Pathol Lab Med; 1988 Feb; 112(2):155-60. PubMed ID: 2447857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intermediate filament complement of the spectrum of nerve sheath neoplasms.
    Gould VE; Moll R; Moll I; Lee I; Schwechheimer K; Franke WW
    Lab Invest; 1986 Oct; 55(4):463-74. PubMed ID: 3531717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases.
    Erlandson RA; Woodruff JM
    Cancer; 1982 Jan; 49(2):273-87. PubMed ID: 7053827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular wall cells contribute to tumourigenesis in cutaneous neurofibromas of patients with neurofibromatosis type 1. A comparative histological, ultrastructural and immunohistochemical study.
    Friedrich RE; Holstein AF; Middendorff R; Davidoff MS
    Anticancer Res; 2012 May; 32(5):2139-58. PubMed ID: 22593502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The electron microscopic spectrum of nerve sheath tumors.
    Dickersin GR
    Ultrastruct Pathol; 1987; 11(2-3):103-46. PubMed ID: 3590349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ultrastructure of schwannoma and neurofibroma of the peripheral nerves.
    Sanguinetti C; Greco F; de Palma L; Specchia N; Toesca A; Nori S
    Ital J Orthop Traumatol; 1991 Jun; 17(2):237-46. PubMed ID: 1797735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign peripheral nerve sheath tumors (neurofibromas) of the lacrimal gland.
    McDonald P; Jakobiec FA; Hornblass A; Iwamoto T
    Ophthalmology; 1983 Dec; 90(12):1403-13. PubMed ID: 6677840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human peripheral nerve sheath neoplasm: expression of Schwann cell-related markers and their relation to malignant transformation.
    Yasuda T; Sobue G; Ito T; Doyu M; Sugiura I; Hashizume Y; Kato K
    Muscle Nerve; 1991 Sep; 14(9):812-9. PubMed ID: 1656253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-100 protein and glial fibrillary acidic protein (GFAP) in experimentally induced and spontaneous tumours of peripheral nerves in BDVI rats. Light microscopic and immunohistochemical study.
    Turusov VS; Cabral JP
    Exp Toxicol Pathol; 1994 Oct; 46(4-5):343-53. PubMed ID: 7894246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral nerve sheath tumors of the head and neck.
    Bruner JM
    Semin Diagn Pathol; 1987 May; 4(2):136-49. PubMed ID: 3313599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of rat central and peripheral nerve tumors induced by ethylnitrosourea.
    Raju NR; Yaeger MJ; Okazaki DL; Lovell K; Koestner A
    Toxicol Pathol; 1990; 18(1 Pt 1):18-23. PubMed ID: 1694597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
    Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
    Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic characteristics of the most frequent peripheral nerve tumors].
    Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
    Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratin expression in schwannoma; a study of 115 retroperitoneal and 22 peripheral schwannomas.
    Fanburg-Smith JC; Majidi M; Miettinen M
    Mod Pathol; 2006 Jan; 19(1):115-21. PubMed ID: 16357842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinal tumors of peripheral nervous system origin.
    Marchevsky AM
    Semin Diagn Pathol; 1999 Feb; 16(1):65-78. PubMed ID: 10355655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
    Dundr P; Povýsil C; Tvrdík D
    Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.